Ruconest is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Santarus, Inc.. The primary component is Conestat Alfa.
Product ID | 68012-350_1ee71ee6-7d7a-4543-bb0f-4b463801b5e1 |
NDC | 68012-350 |
Product Type | Human Prescription Drug |
Proprietary Name | Ruconest |
Generic Name | C1 Esterase Inhibitor Recombinant |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-09-22 |
Marketing End Date | 2022-01-18 |
Marketing Category | BLA / BLA |
Application Number | BLA125495 |
Labeler Name | Santarus, Inc. |
Substance Name | CONESTAT ALFA |
Active Ingredient Strength | 2100 U/1 |
NDC Exclude Flag | N |
Marketing Start Date | 2014-09-22 |
Marketing End Date | 2022-01-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125495 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-09-22 |
Marketing End Date | 2022-01-18 |
Marketing Category | BLA |
Application Number | BLA125495 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-09-22 |
Marketing End Date | 2022-01-18 |
Ingredient | Strength |
---|---|
CONESTAT ALFA | 2100 U/1 |
SPL SET ID: | 6f8b81df-48fe-4798-8d54-fc8f65888489 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
68012-350 | Ruconest | c1 esterase inhibitor recombinant |
69913-350 | Ruconest | c1 esterase inhibitor recombinant |
70383-350 | Ruconest | c1 esterase inhibitor recombinant |
71274-350 | Ruconest | c1 esterase inhibitor recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RUCONEST 85134646 4095324 Live/Registered |
Pharming Intellectual Property B.V. 2010-09-21 |